Status:
COMPLETED
IFACT: Incidental Findings in Advanced Cancer Therapy
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Breast Cancer
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The proposed study, IFACT - Incidental Findings in Advanced Cancer Therapy, will address this research gap by examining MSK patients' attitudes, preferences, and information needs regarding incidental...
Detailed Description
Part 1, the investigators will recruit 40 participants from those already enrolled in existing MSK IRB protocol #12-245 (PI: David Hyman, MD) including male and female patients who have been diagnosed...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Part 1:
- Patient enrolled on MSK protocol #12-245
- Living patient age 18 or older
- Patient diagnosed with breast cancer, colorectal cancer, bladder cancer, or lung cancer
- Patient residing in New York metro-area
- Part 2:
- Living patient age 18 or older
- Consented to Part C of IRB#12-245 and has received results regardless if thereir was a pathogenic variant
- Patient diagnosed with cancer type approved for IRB#12-245 Part C (which are currently breast cancer, gynecological cancer, prostate cancer, and GU non-prostate cancer)breast cancer, colorectal cancer, bladder cancer, or lung cancer
- Patient residing in New York metro-area
- Exclusion Criteria for Part 1 and 2:
- Non-English speakers because we do not have the resources to conduct and translate the interviews into other languages.
- Patient unwilling or unable to provide informed consent.
Exclusion
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 9 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02217891
Start Date
August 1 2014
End Date
February 9 2023
Last Update
February 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065